https://www.taxtmi.com/news?id=72229 India's pharmaceutical exports continued to expand despite global pricing pressure and trade volatility, with outbound shipments reaching over USD 28 billion up to February of the current financial year and recording growth of 5.6 per cent over the corresponding period in the previous year. Export growth was led by formulations, biologicals, vaccines and AYUSH products, while the sector's total export performance in the preceding financial year also showed strong year-on-year growth. Pharmexcil indicated that export expansion would depend on policy prioritisation, market diversification, increased foreign direct investment inflows and improved regulatory efficiency, with a medium-term export target of USD 65 billion by 2030. en-us Sat, 04 Apr 2026 15:16:03 +0530 Sat, 04 Apr 2026 15:16:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=72229 India's pharmaceutical exports continued to expand despite global pricing pressure and trade volatility, with outbound shipments reaching over USD 28 billion up to February of the current financial year and recording growth of 5.6 per cent over the corresponding period in the previous year. Export growth was led by formulations, biologicals, vaccines and AYUSH products, while the sector's total export performance in the preceding financial year also showed strong year-on-year growth. Pharmexcil indicated that export expansion would depend on policy prioritisation, market diversification, increased foreign direct investment inflows and improved regulatory efficiency, with a medium-term export target of USD 65 billion by 2030. News - Sat, 04 Apr 2026 15:16:03 +0530 https://www.taxtmi.com/news?id=72229